Genetic testing of epileptic encephalopathies of infancy: An approach

Canadian Journal of Neurological Sciences

Volumn 40, Issue 1, 2013, Pages 10-16

  Sharma, Suvasini ^a   Prasad, Asuri ^b  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

^b CHILDREN S HOSPITAL OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARX GENE; BRAIN DYSFUNCTION; BRAIN MALFORMATION; CDKL 5 GENE; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; EARLY MYOCLONIC ENCEPHALOPATHY; EEG ABNORMALITY; EPILEPSY OF INFANCY WITH MIGRATING FOCAL SEIZURE; GENE; GENE MUTATION; GENETIC COUNSELING; GENETIC DISORDER; GENETIC SCREENING; HUMAN; INBORN ERROR OF METABOLISM; INTRACTABLE EPILEPSY; LENNOX GASTAUT SYNDROME; OHTAHARA SYNDROME; PCDH 19 GENE; PRIORITY JOURNAL; REVIEW; SCN 1A GENE; SEVERE MYOCLONIC EPILEPSY IN INFANCY; STXBP 1 GENE; WEST SYNDROME;

EID: 84871340833     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100012889     Document Type: Review

References (44)

1. Nabbout R, Dulac O. epileptic encephalopathies: A brief overview. J Clin Neurophysiol. 2003;20:393-7
2. Saitsu H, Kato M, Mizuguchi t, et al. De novo mutations in the gene encoding StXbP1 (MuNC18-1) cause early infantile epileptic encephalopathy. Nat Genet. 2008;40:782-8
3. Sartori S, Polli R, bettella e, et al. Pathogenic role of the X-linked cyclin-dependent kinase-like 5 and aristaless-related homeobox genes in epileptic encephalopathy of unknown etiology with onset in the first year of life. J Child Neurol. 2011;26:683-91
4. Molinari F, Kaminska A, Fiermonte G, et al. Mutations in the mitochondrial glutamate carrier SLC25A22 in neonatal epileptic encephalopathy with suppression bursts. Clin Genet. 2009;76: 188-94
5. Scheffer Ie. Genetic testing in epilepsy: What should you be doing? epilepsy Curr. 2011;11:107-11
6. berkovic SF, Harkin L, McMahon JM, et al. De-novo mutations of t he sod iu m c hanne l gene SCN1A i n alleg e d va c c ine encephalopathy: A retrospective study. Lancet Neurol. 2006;5: 488-92
7. Donat JF. the age-dependent epileptic encephalopathies. J Child Neurol. 1992;7:7-21
8. yamamoto H, Okumura A, Fukuda M. epilepsies and epileptic syndromes starting in the neonatal period. brain Dev. 2011;33: 213-20
9. Ohtahara S, yamatogi y. epilepti c encephalopathies i n early infancy with suppression-burst. J Clin Neurophysiol. 2003;20: 398-407
10. Wang PJ, Lee Wt, Hwu WL, et al. the controversy regarding diagnostic criteria for early myoclonic encephalopathy. brain Dev. 1998;20:530-5
11. yamatogi y, Ohtahara S. early-infantile epileptic encephalopathy with suppressi on-b ursts, Ohtahara synd rom e; its ov erview referring to our 16 cases. brain Dev. 2002;24:13-23
12. Weckhuysen S, Mandelstam S, Suls A, et al. KCNq2 encephalopathy: Emerging phenotype of a neonatal epileptic encephalopathy. Ann Neurol. 2012;71:15-25
13. Coppola G. Malignant migrating partial seizures in infancy: An epilepsy syndrome of unknown etiology. epilepsia. 2009;50 Suppl 5:49-51
14. Carranza Rojo D, Hamiwka L, McMahon JM, et al. De novo SCN1A mutations in migrating partial seizures of infancy. Neurology. 2011;77:380-3
15. Freilich eR, Jones JM, Gaillard WD, et al. Novel SCN1A mutation in a proband with malignant migrating partial seizures of infancy. Arch Neurol. 2011;68:665-71
16. Poduri A, Chopra SS, Neilan eG, et al. Homozygous PLCb1 deletion associated with malignant migrating partial seizures in infancy. epilepsia. 2012;53:e146-50
17. Lux AL, Osborne JP. A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: Consensus statement of the West Delphi group. epilepsia. 2004;45:1416-28
18. Archer HL, evans J, edwards S, et al. CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients. J Med Genet. 2006;43:729-34
19. Suri M. the phenotypic spectrum of ARX mutations. Dev Med Child Neurol. 2005;47:133-7
20. Otsuka M, Oguni H, Liang JS, et al. StXbP1 mutations cause not only Ohtahara syndrome but also West syndrome-result of Japanese cohort study. epilepsia. 2010;51:2449-52
21. Saitsu H, tohyama J, Kumada t, et al. Dominant-negative mutations in alpha-II spectrin cause West syndrome with severe cerebral hypomyelination, spastic quadriplegia, and developmental delay. Am J Hum Genet. 2010;86:881-91
22. Kurian MA, Meyer e, vassallo G, et al. Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy. brain. 2010;133:2964-70
23. Dravet C. the core Dravet syndrome phenotype. epilepsia. 2011;52 Suppl 2:3-9
24. bureau M, Dalla bernardina b. electroencephalographic characteristics of Dravet syndrome. epilepsia. 2011;52 Suppl 2: 13-23
25. Marini C, Scheffer Ie, Nabbout R, et al. the genetics of Dravet syndrome. epilepsia. 2011;52 Suppl 2:24-9
26. Marini C, Mei D, Parmeggiani L, et al. Protocadherin 19 mutations in girls with infantile-onset epilepsy. Neurology. 2010;75: 646-53
27. Scheffer Ie, turner SJ, Dibbens LM, et al. epilepsy and mental retardation limited to females: An under-recognized disorder. brain. 2008;131:918-27
28. Depienne C, bouteiller D, Keren b, et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet. 2009;5:e1000381
29. Chiron C, Dulac O. the pharmacologic treatment of Dravet syndrome. epilepsia. 2011;52 Suppl 2:72-5
30. Gospe SM, Jr. Neonatal vitamin-responsive epileptic encephalopathies. Chang Gung Med J. 2010;33:1-12
31. Liang JS, Shimojima K, takayama R, et al. CDKL5 alterations lead to early epileptic encephalopathy in both genders. epilepsia. 2011;52:1835-42
32. bahi-buisson N, Nectoux J, Rosas-vargas H, et al. Key clinical features to identify girls with CDKL5 mutations. brain. 2008; 131:2647-61
33. Guerrini R, Moro F, Kato M, et al. expansion of the first PolyA tract of ARX causes infantile spasms and status dystonicus. Neurology. 2007;69:427-33
34. Klein KM, yendle SC, Harvey AS, et al. A distinctive seizure type in patients with CDKL5 mutations: Hypermotor-tonic-spasms sequence. Neurology. 2011;76:1436-8
35. Prasad AN, Rupar CA, Prasad C. Methylenetetrahydrofolate reductase (MtHFR) deficiency and infantile epilepsy. brain Dev. 2011;33:758-69
36. Stockler S, Plecko b, Gospe SM Jr, et al. Pyridoxine dependent epilepsy and antiquitin deficiency: Clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. Mol Genet Metab. 2011;104:48-60
37. Mastrangelo M, Leuzzi v. Genes of early-onset epileptic encephalopathies: From genotype to phenotype. Pediatr Neurol. 2012;46:24-31
38. Ottman R, Hirose S, Jain S, et al. Genetic testing in the epilepsies- -report of the ILAe Genetics Commission. epilepsia. 2010; 51:655-70
39. Harkin LA, McMahon JM, Iona X, et al. the spectrum of SCN1Arelated infantile epileptic encephalopathies. brain. 2007;130: 843-52
40. Saitsu H, Kato M, Okada I, et al. StXbP1 mutations in early infantile epileptic encephalopathy with suppression-burst pattern. epilepsia. 2010;51:2397-405
41. Mulley JC, Mefford HC. epilepsy and the new cytogenetics. epilepsia. 2011;52:423-32
42. Miller Dt, Adam MP, Aradhya S, et al. Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86:749-64
43. Mefford HC, yendle SC, Hsu C, et al. Rare copy number variants are an important cause of epileptic encephalopathies. Ann Neurol. 2011;70:974-85
44. Paciorkowski AR, thio LL, Rosenfeld JA, et al. Copy number variants and infantile spasms: Evidence for abnormalities in ventral forebrain development and pathways of synaptic function. eur J Hum Genet. 2011;19:1238-45